Metabolon offers metabolomics services and products, including biomarker discovery and targeted metabolomics analysis. The company provides solutions for various applications such as drug development, precision medicine, and population health studies.

Metabolon

Almost every factor that affects health – from genetics and the microbiome to disease and lifestyle – exerts its influence by altering metabolite levels in the body or other biological system. By producing the most accurate and comprehensive picture of the collection of metabolites, known as the metabolome, from a single biological sample, Metabolon can deliver an instantaneous snapshot of the entire physiology of a living being at a discreet point in time, as well as identify changes in that system brought about the impact of disease, medical intervention, diet or the environment.  This deep and comprehensive view of the metabolome provides  biological insights that cannot be revealed through any other research methodology, enabling life sciences researchers and drug developers to discover answers some of biology’s most difficult questions.

Metabolon's unrivaled capability to look deep into the metabolome has enabled us to build the world’s largest library of compounds that currently includes 5,200+ total known molecules.  Our proprietary Precision Metabolomics™ platform, combined with the world's most experienced metabolomics scientists, delivers biologic insights and identification of novel commercial opportunities for drug discovery and development, through clinical trials and life cycle management. Metabolon’s expertise is also accelerating research and product development for clients in academia, population health, consumer products, and nutrition industries. 

Founded in 2000 and based in Research Triangle Park, North Carolina, Metabolon has conducted more than 10,000 independent and collaborative studies, resulting in 2,000+ publications in leading peer-reviewed journals. For more information about our technology, products and services, please visit www.metabolon.com.

Essex Woodlands Healthcare Partners

Perceptive Advisors

The Aurora Funds

Fletcher Spaght, Inc.

Sumitomo

Syngenta Ventures

Fulcrum Equity Partners

Camden Partners

180 Degree Capital

EW Healthcare Partners

Metabolon, Inc.

At Metabolon, we believe that Purpose is the compass that guides us towards making a real impact. Purpose isn't just a lofty ideal for us – it's the heartbeat of every decision we make.  

Hear from Annie Evans, Senior Director, Head of Core Research at Metabolon about what Purpose means to her. Interested in joining us?  Check out our open positions here: https://lnkd.in/eAKtpmZV  

#PowerofPurpose #MetabolonLife #WorkatMetabolon #CompanyCulture #PurposePassionPerformance #MissionDriven #CompanyValues 

January is #CervicalHealthAwarenessMonth and a time to bring awareness to #cervical #health and cervical cancer prevention. 

>>>Learn more about how Metabolon is committed to further research into targeted therapeutic interventions for cervical cancer: https://bit.ly/48MTEed

The publication explores the complex interplay between #immunometabolic alterations and potential tumor-promoting changes in 3D #cervicalcancer models. Metabolon played a pivotal role in contributing comprehensive #metabolomic #data, providing detailed insights into the #metabolic landscape associated with the 3D cervical cancer microenvironment. Through advanced metabolomic profiling, Metabolon's contribution enhanced the understanding of the intricate relationships between immune responses and metabolic changes in the context of cervical cancer.

#multiomics #omics #biomarkers #biochemistry #phenotype

NEW CASE STUDY! Utilizing a comprehensive #metabolomic profiling approach, this study investigates the potential of #metabolomics in identifying #metabolic markers associated with blood pressure regulation. The findings reveal a set of #metabolites exhibiting significant correlation with blood pressure, highlighting their potential utility as #biomarkers for monitoring and understanding blood pressure dynamics. This research underscores the power of metabolomics in uncovering novel insights into #cardiovascular #health and provides a foundation for future studies exploring the intricate interplay between metabolites and blood pressure regulation.

>>>Access the full case study here for in-depth insights into the methodology and outcomes of this impactful investigation: https://bit.ly/3SeZakw

#multiomics #omics #biochemistry #phenotype #phenotyping

Discover how advances in high-resolution mass spectrometry and access to reliable, reproducible metabolomics data are enabling biopharma projects to progress faster and achieve clinical success more reliably than ever before!

Download this free compendium to explore the role #metabolomics plays in biopharma workflows, the value metabolomics brings to bioprocessing, and how introducing metabolomics into a multi-omics model of drug discovery and drug development can lead to new insights not possible without getting closer to the phenotype.

📘 https://mtbln.co/0v437v

#Metabolon #massspec #biopharma #drugdiscovery


Happy New Year!  Looking to unlock the power of #metabolomics in 2024? Dive into the world of metabolomics studies and discover the five key elements that drive groundbreaking insights into biological systems. From sample collection to advanced analytics, this blog post breaks down the essentials for a successful metabolomics study. Whether you're new to the field or a seasoned researcher, this blog provides valuable insights to enhance your understanding and proficiency in metabolomics. Read more at:  https://bit.ly/47qfDq2

#multiomics #omics #biomarkers #biomarkerdiscovery #biochemistry #phenotype #research #scientificinsights

Visiopharm is a leading provider of AI-driven precision pathology software, operating in the healthcare and technology sectors. The company's main offerings include software tools for research and diagnostics, which assist scientists, pathologists, and image analysis experts in producing accurate data for all types of tissue-based research, and provide diagnostic decision support.

Visiopharm

Creative Proteomics is a competitor of Metabolon in the biotechnology industry. They provide services related to proteomics and other biological research areas.

Creative Proteomics

Biocrates is a competitor of Metabolon in the biotechnology industry. They offer services related to metabolomics and lipidomics, providing solutions for research and diagnostics.

Biocrates

Metabolomic Diagnostics is a competitor of Metabolon in the biotechnology industry. They focus on providing diagnostic solutions based on metabolomic analysis for various applications.

Metabolomic Diagnostics

Metabolon provides scalable, customizable metabolomics solutions that measure inputs from internal and external factors to drive success in answering scientific questions about health and disease. Their work accelerates research in biopharma, population health, consumer products, agriculture, wellness, and academic and government research sectors, ultimately leading to the creation of new treatments that impact individuals and communities globally.

news impact assignment basic	general	Feb 16, 2024 12:37 AM	8912a7ef
public peers	general	Oct 2, 2024 2:59 PM	163c67ea
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Oct 8, 2024 3:55 PM	6b8e8d02
company summary	general
signals	general	Oct 2, 2024 2:59 PM	caef9b2d
crunchbase trigger	general
crunchbase profile	general
li profile	general	Feb 16, 2024 12:37 AM	ec23407a
translate crunchbase fundingrounds	general
peers	general	Oct 2, 2024 2:59 PM	aa6a5715
news basic	general	Oct 2, 2024 2:59 PM	a6532666
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:METABOLON

Metabolon